Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of increasing tumor killing activity of macrophages or monocytes comprising chimeric antigen receptor

Method of increasing tumor killing activity of macrophages or monocytes comprising chimeric antigen receptor

US Patent 11739297 · Granted Aug 29, 2023

Estimated economic value: $5,808,000 ⓘ

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Leadless cardiac pacemaker device configured to provide his bundle pacing2025
Leadless cardiac pacemaker device configured to provide his bundle pacing2023
Modified monocytes/macrophage expressing chimeric antigen receptors and uses the2022
Modified monocytes/macrophage expressing chimeric antigen receptors and uses the2022
Modified monocytes/macrophage expressing chimeric antigen receptors and uses the2022
Modified monocytes/macrophage expressing chimeric antigen receptors and uses the2022
Modified monocytes/macrophage expressing chimeric antigen receptors and uses the2022
Modified monocytes/macrophage expressing chimeric antigen receptors and uses the2022
Constructs for chimeric antigen receptors2022
Constructs for chimeric antigen receptors2022
Constructs for chimeric antigen receptors2022
Modified monocytes/macrophage expressing chimeric antigen receptors and uses the2022